Donald Knauss - McKesson Independent Director
| MCK Stock | USD 562.78 7.29 1.28% |
Director
Mr. Donald R. Knauss is an Independent Director of Mckesson Corporationrationration. Mr. Knauss, age 67, retired from The Clorox Company in 2015, having served as Executive Chairman of the Board from November 2014 until July 2015 and Chairman and Chief Executive Officer from October 2006 until November 2014. He was Executive Vice President of The CocaCola Company and President and Chief Operating Officer for CocaCola North America from February 2004 until September 2006. Prior to his employment with The CocaCola Company, he held various positions in marketing and sales with PepsiCo, Inc. and Procter Gamble and served as an officer in the United States Marine Corporationration. He currently serves as a director of the Kellogg Company and Target Corporationrationration. Mr. Knauss also serves as the Chairman of the Board of Trustees for the University of San Diego and is a member of the Economic Advisory Council of the San Francisco Federal Reserve Board. He was formerly a director of URS Corporationrationration. Mr. Knauss was a director of the Company since October 2014. Mr. Knauss has gained substantial board leadership skills through his chairmanship role at The Clorox Company. He also brings substantial executive experience, including in the roles of Chief Executive Officer, President and Chief Operating Officer, through which he has developed valuable operational insights and strategic and longterm planning capabilities. In addition, Mr. Knauss possesses extensive international business management experience, which provides him with valuable insights into global business strategy. He also possesses extensive retail expertise, which includes experience in the retail pharmacy area. Mr. Knauss also has significant other public company board experience. Having worked outside of the healthcare industry, Mr. Knauss enhances the diverse perspectives on the Board. since 2014.
| Age | 70 |
| Tenure | 10 years |
| Phone | 972 446 4800 |
| Web | https://www.mckesson.com |
McKesson Management Efficiency
The company has Return on Asset of 0.0392 % which means that on every $100 spent on assets, it made $0.0392 of profit. This is way below average. McKesson's management efficiency ratios could be used to measure how well McKesson manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Mark Mlotek | Henry Schein | 68 | |
| Carrie Cox | Cardinal Health | 62 | |
| Colleen Arnold | Cardinal Health | 61 | |
| Steven Paladino | Henry Schein | 67 | |
| John Losh | Cardinal Health | 73 | |
| Mark McGettrick | Owens Minor | 63 | |
| Michael Riordan | Owens Minor | 61 | |
| Gwendolyn Bingham | Owens Minor | 61 | |
| Akhil Johri | Cardinal Health | 59 | |
| Eddie Moore | Owens Minor | 71 | |
| Calvin Darden | Cardinal Health | 69 | |
| Trudi Allcott | Owens Minor | N/A | |
| Bruce Downey | Cardinal Health | 72 | |
| Patricia Hall | Cardinal Health | 67 | |
| Nancy Killefer | Cardinal Health | 66 | |
Management Performance
| Return On Asset | 0.0392 |
McKesson Leadership Team
Elected by the shareholders, the McKesson's board of directors comprises two types of representatives: McKesson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of McKesson. The board's role is to monitor McKesson's management team and ensure that shareholders' interests are well served. McKesson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, McKesson's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lori Schechter, Executive Vice President Chief Compliance Officer, General Counsel | ||
| Holly Weiss, VP Relations | ||
| Pete Slone, Senior Affairs | ||
| W Dunbar, Independent Director | ||
| Bradley Lerman, Independent Director | ||
| LeAnn Smith, Executive Officer | ||
| Kenneth Washington, Independent Director | ||
| M Jacobs, Independent Director | ||
| Kirk Kaminsky, President Business | ||
| Edward Mueller, Independent Chairman of the Board | ||
| Nancy Avila, Chief VP | ||
| James Hinton, Director | ||
| Richard Carmona, Independent Director | ||
| Marie Knowles, Independent Director | ||
| N Coles, Independent Director | ||
| Linda Mantia, Independent Director | ||
| Nancy Flores, Executive Vice President, Chief Technology Officer, Chief Information Officer | ||
| Tracy Faber, Chief Human Resource Officer, Executive Vice President | ||
| Susan Salka, Independent Director | ||
| Kevin Emerson, Interim Senior Vice President Chief Accounting Officer, Controller | ||
| Tom Rodgers, Executive Vice President and Chief Strategy and Business Development Officer | ||
| Paul Smith, Senior Taxes | ||
| Donald Knauss, Independent Director | ||
| Maria Martinez, Independent Director | ||
| Michele JD, Executive Officer | ||
| Brad Lerman, Independent Director | ||
| Kathleen Thompson, Director | ||
| Rachel Rodriguez, Vice Relations | ||
| Michele Lau, Executive Officer | ||
| Britt Vitalone, Chief Financial Officer, Executive Vice President | ||
| Thomas MBA, Executive Officer | ||
| Britt CPA, Executive CFO | ||
| Napoleon Rutledge, Senior Vice President Chief Accounting Officer, Controller | ||
| Francisco Fraga, Chief VP | ||
| Brian Tyler, President, Chief Executive Officer, Chief Operating Officer, Director | ||
| MChristine Jacobs, Independent Director | ||
| Lori JD, Board Advisor | ||
| Dominic Caruso, Independent Director |
McKesson Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is McKesson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.0392 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 77.07 B | ||||
| Shares Outstanding | 126.94 M | ||||
| Shares Owned By Insiders | 0.09 % | ||||
| Shares Owned By Institutions | 89.08 % | ||||
| Number Of Shares Shorted | 1.91 M | ||||
| Price To Earning | 26.98 X | ||||
| Price To Book | 5.04 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in McKesson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy McKesson Stock please use our How to buy in McKesson Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of McKesson. If investors know McKesson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about McKesson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of McKesson is measured differently than its book value, which is the value of McKesson that is recorded on the company's balance sheet. Investors also form their own opinion of McKesson's value that differs from its market value or its book value, called intrinsic value, which is McKesson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because McKesson's market value can be influenced by many factors that don't directly affect McKesson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between McKesson's value and its price as these two are different measures arrived at by different means. Investors typically determine if McKesson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, McKesson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.